These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23563027)

  • 21. Hormonal therapy for epilepsy.
    Stevens SJ; Harden CL
    Curr Neurol Neurosci Rep; 2011 Aug; 11(4):435-42. PubMed ID: 21451944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lamotrigine and catamenial epilepsy.
    Gilad R; Sadeh M; Rapoport A; Dabby R; Lampl Y
    Seizure; 2008 Sep; 17(6):531-4. PubMed ID: 18420429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormonal therapies: progesterone.
    Herzog AG
    Neurotherapeutics; 2009 Apr; 6(2):383-91. PubMed ID: 19332334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of seizures across the menstrual cycle in women with epilepsy.
    Herzog AG; Fowler KM; Sperling MR; Massaro JM;
    Epilepsia; 2015 May; 56(5):e58-62. PubMed ID: 25823700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Specific aspects of the management of women with epilepsy].
    Dupont S
    Presse Med; 2018 Mar; 47(3):251-260. PubMed ID: 29526424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of steroid hormones in women with mild catamenial epilepsy.
    Hussain Z; Qureshi MA; Hasan KZ; Aziz H
    J Ayub Med Coll Abbottabad; 2006; 18(3):17-20. PubMed ID: 17348306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy.
    Herzog AG; Harden CL; Liporace J; Pennell P; Schomer DL; Sperling M; Fowler K; Nikolov B; Shuman S; Newman M
    Ann Neurol; 2004 Sep; 56(3):431-4. PubMed ID: 15349872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel therapeutic approach for treatment of catamenial epilepsy.
    Joshi S; Sun H; Rajasekaran K; Williamson J; Perez-Reyes E; Kapur J
    Neurobiol Dis; 2018 Mar; 111():127-137. PubMed ID: 29274741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of neurosteroids in catamenial epilepsy.
    Reddy DS
    Epilepsy Res; 2004 Dec; 62(2-3):99-118. PubMed ID: 15579299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetazolamide in women with catamenial epilepsy.
    Lim LL; Foldvary N; Mascha E; Lee J
    Epilepsia; 2001 Jun; 42(6):746-9. PubMed ID: 11422329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unbalanced progesterone and estradiol secretion in catamenial epilepsy.
    Bonuccelli U; Melis GB; Paoletti AM; Fioretti P; Murri L; Muratorio A
    Epilepsy Res; 1989; 3(2):100-6. PubMed ID: 2651113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The course of epilepsy and seizure control in pregnant women.
    Shahla M; Hijran B; Sharif M
    Acta Neurol Belg; 2018 Sep; 118(3):459-464. PubMed ID: 29981006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurosteroid regulation of GABA
    Joshi S; Kapur J
    Brain Res; 2019 Jan; 1703():31-40. PubMed ID: 29481795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in sex steroid levels in women with epilepsy on treatment: relationship with antiepileptic therapies and seizure frequency.
    Galimberti CA; Magri F; Copello F; Arbasino C; Chytiris S; Casu M; Ameri P; Perucca P; Murialdo G
    Epilepsia; 2009 Jan; 50 Suppl 1():28-32. PubMed ID: 19125844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermittent levetiracetam treatment in five patients with catamenial epilepsy.
    Liu J; Yu N; Sun H; Liang Y; Xie Y; Chen K
    J Pak Med Assoc; 2015 Jul; 65(7):793-5. PubMed ID: 26160095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical analysis of the effectiveness and safety of vigabatrin].
    Jedrzejczak J; Owczarek K
    Neurol Neurochir Pol; 2000; 34 Suppl 1():177-85. PubMed ID: 10768157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catamenial epilepsy: gynecological and hormonal implications. Five case reports.
    Rodriguez Macias KA
    Gynecol Endocrinol; 1996 Apr; 10(2):139-42. PubMed ID: 8701789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catamenial epilepsy: definition, prevalence pathophysiology and treatment.
    Herzog AG
    Seizure; 2008 Mar; 17(2):151-9. PubMed ID: 18164632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.